Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-003917

Director sold 5,999 shares at $40.04 ($240,200)

  • Director acquired 5,999 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurkijarvi Kalevi · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-14 Exercise or conversion : show line 1 in the form +5,999 $19.05 $114,281 39,099 D
2021-01-14 Sale : show line 2 in the form −5,999 $40.04 $240,200 33,100 D
Open-market sales · 5,999 sh · avg $40.04 · $240,200

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,999 $19.05 2026-06-08 5,999 6,000 D
Loading xslF345X03/doc4.xml…